Here's What Key Metrics Tell Us About Fidelis Insurance (FIHL) Q2 Earnings
The reported revenue compares to the Zacks Consensus Estimate of $645.23 million, representing a surprise of -9.71%. The company delivered an EPS surprise of +200%, with the consensus EPS estimate being -$0.12.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Fidelis Insurance performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Combined Ratio: 103.7% versus the two-analyst average estimate of 108.9%.
Loss Ratio: 55.1% versus 61.8% estimated by two analysts on average.
Revenues- Net premiums earned: $538 million versus $597.55 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +7.4% change.
Revenues- Net investment income: $44.6 million compared to the $47.68 million average estimate based on two analysts. The reported number represents a change of -3% year over year.
View all Key Company Metrics for Fidelis Insurance here>>>
Shares of Fidelis Insurance have returned +7.9% over the past month versus the Zacks S&P 500 composite's +3.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Fidelis Insurance Holdings Limited (FIHL) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Boozt AB (BOZTY) Q2 2025 Earnings Call Highlights: Navigating Revenue Decline with Strategic ...
Revenue: Declined by 3% to SEK1.8 billion, flat in local currency. Booztlet Revenue Growth: Increased by 14% or 17% in local currency. Revenue Decline: Decreased by 6% or 3% in local currency. Adjusted EBIT Margin: 3.4%, down 1.5 percentage points from last year. Gross Margin: 39.1%, down 2.7 percentage points from last year. Free Cash Flow: More than doubled to SEK186 million from SEK90 million last year. Share Buyback: SEK94 million worth of shares repurchased in the quarter. Net Cash Position: SEK75 million at the end of the quarter. Customer Metrics: 53% of customers bought from more than one category, up from 51% last year. Average Order Value: Increased 2% to SEK934. Fulfillment Cost Ratio: Improved to 10.5% from 11.4% last year. Marketing Cost Ratio: Increased to 11.5% from 10.8% last year. Admin and Other Costs Ratio: Decreased by 1.5 percentage points to 9.7%. Financial Guidance for 2025: Net revenue growth of 0% to 6% and adjusted EBIT margin of 4.5% to 5.5%. Free Cash Flow Guidance for 2025: At least SEK500 million. Warning! GuruFocus has detected 3 Warning Sign with BOZTY. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Booztlet's revenue grew by 14% or 17% in local currency, driven by effective inventory clearance strategies. Strong free cash flow more than doubled to SEK186 million, supported by disciplined inventory management and customs repayment. The company repurchased SEK94 million worth of shares, with plans to increase the share buyback program from SEK200 million to SEK300 million. Operational cost improvements were noted, with fulfillment and admin costs improving by close to 2.5-percentage-points combined. Strategic initiatives in AI and hiring are expected to fuel future growth, enhancing customer experience and operational efficiency. Negative Points Reported revenue declined by 3% due to a 3% currency headwind, with seeing a revenue decline of 6% or 3% in local currency. Adjusted EBIT margin for the quarter was 3.4%, down 1.5-percentage-points from last year, impacted by lower gross margins and higher marketing costs. Marketing cost ratio increased to 11.5% from 10.8% last year, with offline marketing not yielding expected returns. Consumer confidence remains low, particularly affecting demand in Denmark and the women's fashion category. Inventory levels were initially too high, necessitating clearance sales that impacted gross margins negatively. Q & A Highlights Q: Can you provide insights into the start of Q3, considering the variations in April, May, and June? A: Normally, we don't provide current trading details, but I can share that we're back to growth, albeit modest. This supports our guidance for the second half. - Hermann Haraldsson, CEO Q: The guidance range seems wide. Is the upper end of the guidance optimistic given H1 sales? A: It's a combination of easier comps, better stock alignment, and optimism for revenue. On costs, we're well-controlled, so the midpoint is a good bet, not the lower end. - Hermann Haraldsson, CEO Q: Can you confirm the underlying margin in Q2 and Q3, excluding Norwegian import duties? A: We have a tailwind from customs of 0.7-percentage-points this quarter, with a full-year impact of around 0.5-percentage-points. - Sandra Gadd, CFO Q: How has the FX rate movement affected your guidance? A: It's too early to say definitively, but our current guidance covers the changes. We'll be more specific in Q3 if needed. - Sandra Gadd, CFO Q: What is the quality of your current inventory, and do you anticipate further clearances in Q3? A: Our inventory is in line with last year, and we have managed to clear excess stock. We are focusing on having the right inventory for especially correcting for the women's category for fall. - Hermann Haraldsson, CEO Q: Will the marketing spend in H2 be neutralized by increased fashion-related marketing? A: The marketing cost ratio was too high in Q2. We aim for a long-term ratio of 10% or below, and we are revisiting our strategy to increase category awareness effectively. - Hermann Haraldsson, CEO Q: What drove the recovery in June, and was it widespread across regions? A: The recovery was driven by improved weather and consumer confidence. Denmark remains more depressed, while Sweden is performing well. - Hermann Haraldsson, CEO Q: Have you seen any changes in competition from ultra-fast fashion players? A: Competition remains intense, but some ultra-fast fashion players are losing ground. The decline in women's dresses may be due to cheaper, trend-driven purchases. - Hermann Haraldsson, CEO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
29 minutes ago
- Yahoo
Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Revenue Growth: 6% increase for the quarter and 5% for the fiscal year. Cash from Operations: $30 million for the quarter and $71 million for the fiscal year. Gross Margin Expansion: 370 basis points for the quarter and 280 basis points for the year. EBITDA Margin: 8.5% for the fourth quarter and 7.7% for the fiscal year. Gross Profit: Increased to $25.4 million for the fourth quarter. Operating Cash Flow: $30.2 million for the quarter, a 55% improvement over the same period last year. Free Cash Flow: $64.5 million for the fiscal year. Capital Expenditures: $7.2 million for the fiscal year. Cash Position: Ended the year with $84.6 million in cash. Available Credit Facilities: Approximately $52 million available. Warning! GuruFocus has detected 4 Warning Signs with CSAN. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strattec Security Corp (NASDAQ:STRT) ended fiscal 2025 with strong sales growth and expanded margins. The company generated $30 million in cash from operations for the quarter and $71 million for the fiscal year. Revenue grew 6% in the quarter and 5% for the year, driven by strategic pricing initiatives and higher demand. Gross margin expanded by 370 basis points for the quarter and 280 basis points for the year. The company has a healthy cash position of $84.6 million and approximately $52 million available under revolving credit facilities. Negative Points The company faces ongoing tariff expenses, with an estimated annual cost increase between $5 million to $7 million. Higher labor costs in Mexico are impacting the company's financials. The fiscal year 2026 is expected to see lower North American automotive production, potentially affecting sales. The company is still in the early stages of its transformation process, with long-term changes needed. There is uncertainty in the market, which may impact the company's ability to maintain its current cash flow levels. Q & A Highlights Q: How far along is Strattec in its transformation process, and what does the future look like for this initiative? A: Jennifer Slater, President and CEO, stated that Strattec is still in the early stages of its transformation. While they have addressed much of the low-hanging fruit in fiscal year 2025, future transformation efforts will be more long-term in nature. Q: Is Strattec considering exiting or divesting any product lines as part of its transformation? A: Jennifer Slater mentioned that Strattec is refocusing its engineering efforts on products with more growth potential, such as power access products and digital key fobs, rather than crowded markets like the switch product line. Q: What is the outlook for Strattec's gross margins in fiscal 2026? A: Matthew Pauli, CFO, indicated that while fiscal 2025 ended with a 15% gross margin, fiscal 2026 is expected to see revenues down to flattish. However, they anticipate tailwinds from pricing actions and restructuring efforts, balanced by inflationary pressures and volume headwinds. Q: How does Strattec plan to utilize its substantial cash reserves, and what is considered an appropriate cash cushion? A: Jennifer Slater explained that the company is comfortable with its current cash position, which provides stability amid market uncertainties. They are focusing on transforming the business and will consider cash allocation for shareholder value once there is more market certainty. Q: What are Strattec's plans for new product offerings or revenue opportunities in the next three to five years? A: Jennifer Slater stated that Strattec is focusing on expanding its customer base within its current product portfolio, particularly in power access and digital key products, while also exploring opportunities with new customers. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
29 minutes ago
- Yahoo
BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLGO) has maintained its net stockholders' equity at around $6 million despite recent losses, showcasing effective capital management. The company has seen a significant increase in service revenues, rising from $300,000 to $1.2 million in the first half of the year. BioLargo Inc (BLGO) has successfully shipped its AEC unit to New Jersey, with validation work to be conducted by state and federal EPA, enhancing credibility. The company has raised $3.3 million in its subsidiary, Clyra Medical, indicating strong investor confidence in its potential. BioLargo Inc (BLGO) is pursuing a capital-conserving strategy by forming joint ventures for battery manufacturing, leveraging public funding and partnerships. Negative Points BioLargo Inc (BLGO) experienced a decline in revenue, with $3 million in the recent quarter compared to $5 million in the same period last year. The company faces uncertainty with its partner Ikigai and Pooph, impacting cash flow and financial forecasting. There is a significant delay in the commercialization of Clyra's wound care product, raising concerns about execution timelines. BioLargo Inc (BLGO) has increased debt obligations, primarily related to Clyra's preparation for product launch. The company is operating under financial pressure due to reduced cash flow from Pooph sales, necessitating cautious financial management. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BLGO. Q: Can you provide any additional insight into the challenges and successes to the barriers to entry for the salinity battery? A: Dennis Calvert, CEO, explained that the primary challenges include technical proof of claim, scaling up manufacturing, and regulatory hurdles. The company has achieved significant technical milestones and is working on scaling up production. Regulatory barriers are relatively low, focusing mainly on safety data and UL certification. The company is confident in its technology and is working towards proving its claims and securing partnerships. Q: Will BioLargo be funding the cost to build battery factories? Will you be involved in designing and building the factories? A: Dennis Calvert, CEO, stated that BioLargo will not be funding the factories directly. Instead, they will act as a vendor, providing engineering services, project management, and technology transfer. The factories will be financed through partnerships, public funding, and other financial arrangements, allowing BioLargo to focus on leveraging its core competencies. Q: What is the latest on New Jersey and the AEC project? A: Dennis Calvert, CEO, reported that the AEC unit has been shipped and is being set up in Lake Stockholm. The state and federal EPA will participate in validation work, which is crucial for future customer demonstrations. The company is excited about this significant milestone and will announce the go-live date soon. Q: How can you be so confident about Clyra given that it's taken so long? A: Dennis Calvert, CEO, expressed confidence in Clyra due to recent investments of $3.3 million and the technical prowess of their invention. The company is preparing for a significant product launch with strong partnerships in place. They aim to complete third-party testing and FDA paperwork by the end of the year, targeting a Q1 launch. Q: Do you have insight on Pooph's operations as far as advertising spend, the number of stores that they're in? A: Dennis Calvert, CEO, mentioned limited insight into Pooph's operations, making it difficult to forecast. However, he noted that Pooph had previously achieved a $50 million run rate and was in 40,000 stores. The company remains optimistic about Pooph's potential but is cautious due to uncertainties. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
